26 Sep 2018 --- OptiBiotix Health has launched a new cholesterol management range, coined CholBiome, that harnesses probiotics for heart health. The range uses OptiBiotix’s patented probiotic Lactobacillus plantarum (LPLDL), which the company recently enabled to be developed as a biotherapeutic pharmaceutical product for the first time following a deal with an unnamed US-based pharmaceutical company.
